Table 2

Baseline characteristics of the entire cohort of 844 patients

Presentation and initial treatment
 Age, years62.5 (54.3, 70.2)
 Man77.9
 Admission diagnosis 
  STEMI51.7
  NSTEMI37.7
  UAP10.6
 Culprit artery
  RCA33.1
  LM2.5
  LAD31.9
  LCX16.5
 Coronary angiography performed94.4
 Percutaneous coronary intervention86.3
 Maximum CK during admission (iU/L)513 (200, 1370)
Cardiovascular risk factors
 Current smoking40.5
 Diabetes mellitus23.5
 Hypertension55.5
 Hypercholesterolaemia49.3
Cardiovascular history
 Prior percutaneous coronary intervention26.2
 Prior coronary artery bypass grafting10.0
 Prior myocardial infarction26.9
 Prior heart failure2.4
 Valvular heart disease2.2
 Prior stroke9.0
 Peripheral artery disease8.9
Medication at first blood sample moment
 Aspirin95.3
 P2Y12 inhibitor95.2
 Vitamin K antagonist6.8
 Statin96.2
 β-blocker89.8
 ACE inhibitor or ARB82.9
  • Continuous data are presented as median (25th, 75th percentiles) values. Categorical data are presented as percentages. There are no missing data for any of the aforementioned variables.

  • ARB, angiotensin II receptor blocker; CK, creatine kinase; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main coronary artery; MI, myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; RCA, right coronary artery; STEMI, ST-elevation myocardial infarction; UAP, unstable angina pectoris.